OBJECTIVES: Synthetic transvaginal mesh (TVM) was developed to improve outcomes of native-tissue vaginal prolapse repair. TVM use has many recognized potential complications and it is unclear whether surgical treatment resolves these associated symptoms. The primary aim of this study was to describe outcomes in women undergoing surgery for TVM complications. MATERIALS AND METHODS: This is a retrospective cohort study of women who underwent surgical revision of synthetic TVM (TVM revision, index surgery). Chart review to obtain baseline clinicaldemographic information, operative notes, and preoperative symptom specific distress and impact questionnaire data and Urinary Impact Questionnaire (UIQ-7)] was performed. Eligible women were sent follow-up questionnaires that assessed: reasons for index surgery, presence of dyspareunia, the same preoperative validated measures of symptom specific distress and impact questionnaires, Patient Global Impression of Improvement (PGI-I) and Patient Satisfaction Questionnaire (PSQ) after TVM revision surgery. Minimum time from index surgery was 12 months. Patients were excluded if undergoing both revision/removal of midurethral sling (MUS) and TVM or mesh from a sacrocolpopexy. Patients could have concomitant native tissue repairs at time of TVM revision/removal. The two-sample t-test and Wilcoxon-Mann-Whitney test and Chisquare tests were used as appropriate. Multivariable logistic regression was utilized to identify variables independently associated with satisfaction with surgery. A p value of < 0.05 was considered statistically significant. RESULTS: One hundred fifteen eligible women were identified and 37.4% (43/115) responded to the questionnaire, 13.9% (16/115) declined participation or were deceased; 48.6% (56/115) did not respond. Non-responders had a greater proportion of combined anterior and posterior mesh placement (42.9% vs 18.6%, p ¼ 0.01) and complete mesh removals (41.1 vs 20.9, p ¼ 0.03). Pain was the most common reason for surgery 57% (n ¼ 56), followed by vaginal mesh erosion 56% (N ¼ 55), and dyspareunia 33.3% (n ¼ 33). Post-operative assessments of responders revealed that 52% reported improvement in dyspareunia, and 51% were satisfied with surgery. Post-operatively, women who were satisfied (n ¼ 22) vs. not satisfied (N ¼ 15) were more likely to have improvement in pain (58% vs. 23%, p ¼ 0.05) and dyspareunia (79% vs. 30.8%, p ¼ 0.05), lower UDI-6, POPDI-6, POPIQ-7, UIQ-7 scores (all p < 0.0001) and higher PGI-I scores (p < 0.0001). Multivariable logistic regression showed that women with resolution of dyspareunia were 12 times more likely to be satisfied, aOR ¼12.3, 95% CI ¼ 1.1-142.5 and there was no association between pain resolution and satisfaction aOR ¼ 0.8, 95% CI ¼ 0.1-10.2. CONCLUSION: Women described vaginal/pelvic pain, vaginal mesh erosion, and dyspareunia as the main reasons for mesh revision surgery. Overall, 51% of women were completely satisfied with their surgery. Women with resolution of dyspareunia were over 12 times more likely to be satisfied with their mesh revision surgery. These results can help to inform to expectations of women presenting with mesh complications.
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